Mutations or dysregulation of AQP1 can lead to several clinical conditions. For instance, altered AQP1 expression is associated with disorders such as nephrogenic diabetes insipidus, pulmonary edema, and brain edema. Understanding the role of AQP1 in these conditions can aid in developing targeted therapies.